Back
Travere Therapeutics Vs. Onto Innovation Industry Stock Comparison
Sell
47
TVTX
Travere Therapeutics
Last Price:
14.3600
Seasonality Move:
-3.64%
Sell
50
ONTO
Onto Innovation
Last Price:
187.66
Seasonality Move:
5.88%
Sell
47
Travere Therapeutics (TVTX)
is a Sell
Is Travere Therapeutics a Buy, Sell or Hold?
- The current Travere Therapeutics [TVTX] share price is $14.4000. The Score for TVTX is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- TVTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Onto Innovation (ONTO)
is a Sell
Is Onto Innovation a Buy, Sell or Hold?
- The current Onto Innovation [ONTO] share price is $192.05. The Score for ONTO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- ONTO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
TVTX Stock Price Chart
What is Travere Therapeutics's stock price today?
-
The Travere Therapeutics share price today is $14.4000
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.
ONTO Stock Price Chart
What is Onto Innovation's stock price today?
-
The Onto Innovation share price today is $192.05
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ONTO is experiencing slight selling pressure.
TVTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.29 | Buy |
| Relative Strength Index (14 RSI): | 82.47 | Buy |
| Chaikin Money Flow: | 17512 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.396 - 12.256) | Buy |
| Bollinger Bands (100): | (6.5589 - 10.3189) | Buy |
ONTO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -2.78 | Sell |
| Relative Strength Index (14 RSI): | 47.7 | Sell |
| Chaikin Money Flow: | -25547 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (188.23 - 211.53) | Sell |
| Bollinger Bands (100): | (189.61 - 226.47) | Sell |
TVTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.96 | Buy |
| 20-day SMA: | 10.72 | Buy |
| 50-day SMA: | 9.89 | Buy |
| 200-day SMA: | 8.25 | Buy |
| 8-day EMA: | 12.93 | Buy |
| 20-day EMA: | 11.4 | Buy |
| 50-day EMA: | 10.02 | Buy |
| 200-day EMA: | 9.3 | Buy |
ONTO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 188.39 | Buy |
| 20-day SMA: | 198.2 | Sell |
| 50-day SMA: | 198.92 | Sell |
| 200-day SMA: | 187.52 | Buy |
| 8-day EMA: | 191.7 | Buy |
| 20-day EMA: | 194.32 | Sell |
| 50-day EMA: | 198.75 | Sell |
| 200-day EMA: | 184.83 | Buy |
Travere Therapeutics Earnings Growth & TVTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.55 per share, an increase next quarter of $0.36 per share, a decrease this year of $2.18 per share, and an increase next year of $2.31 per share.
Onto Innovation Earnings Growth & ONTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.45 per share, an increase this year of $1.57 per share, and an increase next year of $1.33 per share.
Travere Therapeutics Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Onto Innovation Technical Analysis
| Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||